04-05-2021 07:15 PM | Source: (Reuters)
India's Panacea Biotec to produce 100 million Sputnik V doses annually - RDIF
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
MOSCOW - Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.
RDIF did not say when production would begin.
(Reporting by Vladimir Soldatkin; Writing by Alexander Marrow, ediitng by Emelia Sithole-Matarise)
Latest News
Asset classes in action globally - Indian equities k...
Buy ICICI Securities Ltd For Target Rs.704 - Motilal...
Buy Equitas Small Finance Bank Ltd Strong show led b...
Buy Angel One Ltd Strong show led by surge in orders...
Who is Pragya Misra, Sam Altman-run OpenAI's 1st emp...
How Adani Ports unlocked growth potential of India's...
Environment-tech sector in India raised $7.3 billion...
Kunal Shah's CRED receives in-principle approval for...
Climate-smart deeptech firm Ecozen raises $30 mn fro...
India discussed oil market volatility with OPEC chie...
